Naziv |
Akcije |
Reiner, Ivan; Roohi, Mohi-Ud-Din; Apporva, Chawla; Pooja, Sharma; Prince, Ahad Mir; Faheem, Hyder Potoo; Reiner, Željko; Dilek, Arslan Ateşşahin; Javad, Sharifi-Rad; Reyaz, Hassan Mir et al.
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects // European journal of medical research, 345 (2023), 28; 1-35. doi: 10.1186/s40001-023-01275-4. |
|
Pavić, Eva ; Rahelić, Valentina ; Reiner, Željko ; Vranešić Bender, Darija ; Vrdoljak, Ivica ; Martinis, Irena ; Mesarić, Nikola ; Klobučar, Sanja ; Baretić, Maja ; Canecki Varžić, Silvija et al.
Smjernice za prehranu kod šećerne bolesti u odrasloj dobi // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 145 (2023), 3-4; 67-97 |
|
Reiner, Ivan; Habib, Yaribeygi; Mohammad Amin, Hemmati; Fatemeh, Nasimi; Mina, Maleki; Tannaz, Jamialahmadi; Reiner, Željko; Amirhossein, Sahebkar
Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats // Journal of clinical medicine, 3815 (2023), 12; 1-12. doi: 10.3390/jcm12113815. |
|
Štimac, Davor ; Klobučar Majanović, Sanja ; Baretić, Maja ; Bekavac Bešlin, Miroslav ; Belančić, Andrej ; Crnčević Orlić, Željka ; Đorđević, Veljko ; Marčinko, Darko ; Miličić, Davor ; Mirošević, Gorana et al.
Hrvatske smjernice za liječenje odraslih osoba s debljinom // Acta medica Croatica, 76 (2022), 1; 3-18 |
|
Merćep, Iveta ; Strikić, Dominik ; Slišković, Ana Marija ; Reiner, Željko
New Therapeutic Approaches in Treatment of Dyslipidaemia—A Narrative Review // Pharmaceuticals, 15 (2022), 7; 839, 13. doi: 10.3390/ph15070839 |
|
Štimac, Davor ; Klobučar Majanović, Sanja ; Baretić, Maja ; Bekavac Bešlin, Miroslav ; Belančić, Andrej ; Crnčević Orlić, Željka ; Đorđević, Veljko ; Marčinko, Darko ; Miličić, Davor ; Mirošević, Gorana et al.
Hrvatske smjernice za liječenje odraslih osoba s debljinom // Medix (Zagreb), (2022), 152; 1-30 |
|
Pećin, Ivan ; Leskovar, Dunja ; Šabić, Marina ; Perica, Dražen ; Šućur, Nediljko ; Godan Hauptman, Ana ; Merćep, Iveta ; Borovečki, Fran ; Premužić, Vedran ; Jelaković, Bojan et al.
Prophylactic therapeutic plasma exchange in pregnant woman with Familial Chylomicronemia Syndrome – A case report // Transfusion and apheresis science, 61 (2022), 3; 103346, 5. doi: 10.1016/j.transci.2021.103346 |
|
(ACS EuroPath Central & South European Countries Project) 3. Banach M, Penson PE, Vrablik M, Bunc M, Dyrbus K, Fedacko J, Gaita D, Gierlotka M, Jarai Z, Magda SL, Margetic E, Margoczy R, Durak-Nalbantic A, Ostadal P, Pella D, Trbusic M, Udroiu CA, Vlachopoulos C, Vulic D, Fras Z, Dudek D, Reiner Ž
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP) Pharmacology Research, (2021), 166; 105499, 9. doi: 10.1016/j.phrs.2021.105499 |
|
(ESC Scientific Document Group) Visseren, Frank L J ; Mach, François ; Smulders, Yvo M ; Carballo, David ; Koskinas, Konstantinos C ; Bäck, Maria ; Benetos, Athanase ; Biffi, Alessandro ; Boavida, José-Manuel ; Capodanno, Davide et al.
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice // European heart journal, 42 (2021), 34; 3227-3337. doi: 10.1093/eurheartj/ehab484 |
|
(ODYSSEY OUTCOMES Committees and Investigators) Schwartz, Gregory G. ; Szarek, Michael ; Bittner, Vera A. ; Diaz, Rafael ; Goodman, Shaun G. ; Jukema, J. Wouter ; Landmesser, Ulf ; López- Jaramillo, Patricio ; Manvelian, Garen ; Pordy, Robert et al.
Lipoprotein(a) and benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterol // Journal of the American College of Cardiology, 78 (2021), 5; 421-433. doi: 10.1016/j.jacc.2021.04.102 |
|